<DOC>
	<DOCNO>NCT01625403</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety recombinant human B-type natriuretic peptide ( rhBNP ) heart renal function patient acute decompensated heart failure ( ADHF ) acute renal injury ( AKI ) .</brief_summary>
	<brief_title>Recombinant BNP Heart Renal Function Acute Heart Failure</brief_title>
	<detailed_description>Patients acute decompensated heart failure ( ADHF ) acute renal injury ( AKI ) randomize receive standard care without additional rhBNP . Clinical heart function , LVEF , SCr , GFR laboratory parameter evaluate .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>acute heart failure acute renal injury tolerate rhBNP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Recombinant BNP</keyword>
	<keyword>Diuretics</keyword>
	<keyword>Acute decompensated heart failure</keyword>
	<keyword>Acute renal injury</keyword>
	<keyword>Heart function</keyword>
	<keyword>Renal function</keyword>
</DOC>